KRT5 and skin neoplasm: On the other hand, overexpression of EP2 in the skin via a K5 promoter enhances sensitivity to DMBA/TPA-induced skin tumor development with increased tumor angiogenesis and TPA-induced hyperplasia and inflammation [245].